The Lancet Respiratory Medicine: Intermittent montelukast in children aged 10 months to 5 years with wheeze (WAIT trial)

A multicenter, randomized, placebo-controlled trial

2014-09-09

(Press-News.org) This study of 1358 children investigated whether intermittent montelukast (a drug widely used to treat wheeze and other asthmatic symptoms) compared with placebo, reduced wheezing episodes in children aged 10 months to 5 years, and whether patient outcome differed according to genotype. Study authors found that intermittent montelukast only reduced wheezing episodes in children with arachidonate 5-lipoxygenase (ALOX5) gene promoter 5/5, a gene that has previously been associated with a better response to montelukast in adults. There was no correlation with reduced wheezing episodes for children without this specific genotype. Therefore the researchers call for more research into the effects of montelukast in children with this genetic subtype.

INFORMATION: END

ELSE PRESS RELEASES FROM THIS DATE:

Tip sheet from Annals of Internal Medicine, Sept. 9, 2014

2014-09-09

1. Health insurance not affordable for many under Affordable Care Act For many younger adults, the penalty for not buying health insurance may be less than the price of the least expensive plan available under the Patient Protection and Affordable Care Act (ACA), according to a study being published in Annals of Internal Medicine. The ACA aims to expand health care coverage in part by providing subsidies to individuals with low annual incomes. The law mandates that individuals purchase health insurance or pay a penalty. The penalty is waived if the cost of the least-expensive ...

Should lung cancer screening be covered for Medicare beneficiaries?

2014-09-09

1. Should lung cancer screening be covered for Medicare beneficiaries? Experts analyze evidence from the National Lung Screening Trial Researchers for the Centers for Medicare and Medicaid Services (CMS) analyze evidence on the benefits and harms of lung cancer screening by age in a study being published in Annals of Internal Medicine. Smoking is the most important risk factor for developing lung cancer. The National Lung Screening Trial (NLST) reported a reduction in lung cancer mortality in high-risk participants aged 55 to 74 who were randomly assigned to screening ...

September/October 2014 Annals of Family Medicine Tip Sheet

2014-09-09

Illinois' Medicaid Primary Care Case Management Program Associated With Substantial Savings, Reductions in Inpatient and Emergency Care and Improvements in Quality Measures Illinois was an early leader in comprehensive Medicaid reform, implementing a primary care case management program, Illinois Health Connect, and a complementary disease management program, Your Healthcare Plus, in 2006. The programs aimed to promote preventive care, reduce the redundancy of services through continuity of care with a primary care provider, and improve the management of chronic diseases. ...

Researchers improve severe asthma care through new, antibody-based treatment

2014-09-09

September 8, 2014 – Hamilton, ON – A team of researchers at McMaster University and St. Joseph's Healthcare Hamilton have successfully evaluated a new, antibody-based drug for certain patients with severe asthma. The drug – named mepolizumab – can replace traditional, steroid-based treatments for a specific subset of patients, resulting in improved outcomes and reduced side effects. The study and manuscript, published in the New England Journal of Medicine was led in Canada by Dr. Parameswaran Nair, staff respirologist, Firestone Institute for Respiratory Health at ...

Patients with advanced dementia continue receiving medications of questionable benefit

2014-09-08

Bottom Line: More than half of nursing home residents with advanced dementia (a terminal illness marked by severe cognitive impairment and functional dependence) continue to receive medications of questionable benefit (including medications to treat dementia and lower cholesterol) at substantial financial cost. Author: Jennifer Tjia, M.D., M.S.C.E., of the University of Massachusetts Medical School, Worcester, and colleagues. Background: The Institute of Medicine recommends clinicians minimize interventions in patients with life-limiting disease and instead focus ...

Access to care among young adults increases after health insurance expansion

2014-09-08

Bottom Line: Health insurance coverage increased, as expected, among 19- to 25-year-olds after the Patient Protection and Affordable Care Act (PPACA) allowed them to remain on their parents' insurance longer but there were no significant changes in perceived health status or the affordability of health care. Author: Meera Kotagal, M.D., M.P.H., of the University of Washington, Seattle, and colleagues. Background: Nearly 1 in 3 young adults ages 19 to 25 years lacked health insurance in 2009. An early provision of the PPACA implemented in 2010 mandated that insurance ...

Study examines immunosuppressant effect on central nervous system disorder

2014-09-08

Bottom Line: In patients with neuromyelitis optica spectrum disorder (NMOSD, an autoimmune inflammatory disease of the central nervous system similar to multiple sclerosis but even more debilitating), the immunosuppressant medication mycophenolate mofetil (MMF) appears to reduce the frequency of relapse, stabilize or improve disabilities and be well tolerated by patients. Author: So-Young Huh, M.D., of the University College of Medicine, Busan, Korea, and colleagues. Background: Disabilities from NMOSD arise due to acute attacks and just one or two attacks can lead ...

JAMA Internal Medicine commentary: 'Improving Prescribing for Patients Late in Life'

2014-09-08

INDIANAPOLIS -- Older adults are typically prescribed a large number of medications, often including drugs that should not be taken by individuals late in life. In a commentary published online by JAMA Internal Medicine on September 8, Regenstrief Institute investigator Greg Sachs, M.D., calls for physicians to carefully review older patients' medication lists. According to Dr. Sachs, current prescribing guidelines fail to adequately address instances in which specific drugs are not beneficial or may even be harmful to older adults. Current guidelines also fail to identify ...

Sodium's influence on blood pressure statistically insignificant

2014-09-08

A new study published in American Journal of Hypertension finds evidence that increased Body Mass Index, age, and non-sodium dietary factors are much more closely related to increases in systolic blood pressure than sodium intake. The study, "Relationship between nutrition and blood pressure: A cross-sectional analysis from the NutriNet-Santé study, a French web-based cohort study," measured the effects of sodium intake, Body Mass Index, physical activity, alcohol consumption, and non-sodium dietary factors on the blood pressure of 8,670 French adults and concluded ...

Agricultural revolution in Africa could increase global carbon emissions

2014-09-08

WEST LAFAYETTE, Ind. - Productivity-boosting agricultural innovations in Africa could lead to an increase in global deforestation rates and carbon emissions, a Purdue University study finds. Historically, improvements in agricultural technology have conserved land and decreased carbon emissions at the global level: Gaining better yields in one area lessens the need to clear other areas for crops, sidestepping a land conversion process that can significantly raise the amount of carbon dioxide released into the atmosphere. Agricultural advances in Africa, however, could ...

Wiley advances Knowitall Solutions with new trendfinder application for user-friendly chemometric analysis and additional enhancements to analytical workflows

The Lancet Respiratory Medicine: Intermittent montelukast in children aged 10 months to 5 years with wheeze (WAIT trial)

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: